Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML St (Q73295165)
Jump to navigation
Jump to search
scientific article published on 01 January 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML St |
scientific article published on 01 January 2000 |
Statements
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group (English)
A Hochhaus
A Reiter
S Saussele
A Reichert
M Emig
J Kaeda
B Schultheis
U Berger
P C Shepherd
N C Allan
R Hehlmann
J M Goldman
1 January 2000